Frankly Speaking About Family Medicine

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-509

Overview: Listen in to sharpen your prescribing confidence when treating acute sinusitis. This episode covers the latest recommendations on when antibiotics are truly indicated, plus the evidence on amoxicillin alone vs amoxicillin-clavulanate—so you can select the right agent, reduce adverse effects, and avoid sacrificing outcomes in uncomplicated cases.

Episode resource links:

Savage TJ, Butler AM, Kronman MP, et al. Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults. JAMA. 2026;335(19):1694-1705.

 

Payne SC, McKenna M, Buckley J, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngol Head Neck Surg. 2025;173 Suppl 1:S1-S56.

Guest: Alan M. Ehrlich, MD, FAAFP
 
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-508

Overview: We’ve long understood cardiovascular disease, hemorrhage, hypertension, and infection as the leading killers of pregnant patients. A recent analysis challenges that, finding the leading causes are now overdose, homicide, and suicide. Join us as we unpack what this means for clinicians, explore racial and age disparities, and discuss how primary care clinicians can better protect maternal health.

Episode resource links:

Identify unintentional drug overdose and violence (homicide and suicide) as the leading causes of maternal death in the United States from 2018–2023, surpassing traditional obstetric complications

Describe racial, ethnic, and age-related disparities in pregnancy-associated mortality due to overdose, homicide, and suicide

Apply an updated, comprehensive approach to screening and counseling pregnant and postpartum patients that incorporates substance use, intimate partner violence, and mental health risk factors

Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-507

Overview: Falls in older adults can have devastating consequences; substance use and prescription medications are often-overlooked risk factors. Tune in to explore how screening for substance use in a primary care environment may decrease fall and related injury risk in adults over 55. Come away with stronger identification and prevention practices.

Episode resource links:

Babu KM, Haddad YK, Krotulski AJ, Causey ST, Vargas-Torres CC, Martinez PM, Goldberg EM, Dorfman JD, Bailey M, Chapman BP, Graham P, Lai JT, Saif R, Elhoussan R, Capeta Romero A, Londoño-Barreras R, Walton SE, Thomas DD, Logan BK, Merchant RC. Relationship of ethanol, cannabinoids, benzodiazepines, and opioids to serious injuries from falls in adults aged 55 and older. J Emerg Med. 2026;84:46-58. doi:10.1016/j.jemermed.2025.12.017

Colón-Emeric CS, McDermott CL, Lee DS, Berry SD. Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults: A Review. JAMA. 2024;331(16):1397–1406. doi:10.1001/jama.2024.1416

US Preventive Services Task Force. Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;332(1):51–57. doi:10.1001/jama.2024.8481

Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-506

Overview: Overview copy

Episode resource links:

LaMonte MJ, Hyde ET, Nguyen S, et al. Muscular Strength and Mortality in Women Aged 63 to 99 Years. JAMA Netw Open. 2026;9(2):e2559367. doi:10.1001/jamanetworkopen.2025.59367

Free evidence-based resources for strength training
o Exercise & Physical Activity: Your Everyday Guide from the National Institute on Aging
o Senior_Strength_Training_Workouts.pdf

Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-505

Overview: The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) reflects the true complexity of this diagnosis—a condition that extends beyond ovarian cysts and reproductive health. Listen in as we explore what drove the name change, how it better reflects the condition’s complexity, and what current evidence says about prevalence, risk, and whole-body management strategies for your patients.

Episode resource links:

Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S., Joham, A. E., Costello, M. F., ... & Piltonen, T. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet.

 

Tewari, S., Khalua, R. K., & Parida, S. (2026). Redefining polycystic ovary syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS): implications for diagnosis, pathophysiology and clinical management. Int J Gynaecol Sci, 8(1), 17-25.

 

Tewari, S., Pramanik, P., Patra, T., & MK, M. (2026). From Reproductive Disorder to Metabolic Syndrome: The Evolution of Polycystic Ovary Syndrome (PCOS) into Polyendocrine Metabolic Ovarian Syndrome (PMOS). Journal of Pharmacognosy and Phytochemistry, 15(3), 329-337.

Guest: Mariyan L. Montaque, DNP, FNP-BC
 
Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.